BOB体育

My name is Dr. Raymond Mailhot, and I am an associate professor in the Department of Radiation Oncology at the University of Florida. I completed my undergraduate and medical training at Washington University in St. Louis, and my post graduate training at Harvard University and New York University, where I served as chief resident. I am pursuing a career in academic medicine with a clinical focus on pediatric cancers, Hodgkin lymphoma and breast cancer.

With a research focus on cancer outcomes and disparities, I have published more than 60-peer reviewed articles. My research has been published in many esteemed journals, such as Nature Medicine and JAMA Oncology. I have also presented my research at a variety of international medical conferences.

Beyond my research, I am passionate about improving outcomes for cancer survivors, particularly children, adolescents and young adults. Additionally, I have an established theory in addressing healthcare disparities. I am a Latino radiation oncologist and lead the Workforce Committee for the Council on Health Equity, Diversity and Inclusion for the American Society for Radiation Oncology (ASTRO) as Vice Chair, and I serve as Diversity and Inclusion Chair for the Particle Therapy Co-Operative Group (PTCOG). For these accomplishments, I have served as a reviewer for the NIH Community Partnerships to Advance Science for Society (ComPASS) Community-Led, Health Equity Structural Interventions (CHESI) initiative. I have led the COG evaluation of disparate allocation of radiotherapy for children with Hodgkin lymphoma and the COG report on radiotherapy indications for relapsed/refractory Hodgkin lymphoma. With my practice, I am committed to improving outcomes for patients from all backgrounds as well as improving the workforce diversity in radiation oncology. My research on Hodgkin lymphoma led to my receipt of the Young Investigator Award for PTCOG 61.

Currently, I am a member of the NCI鈥檚 inaugural cohort of the Early Investigator Advancement Program (EIAP), as well as a recipient of the Robert A. Winn Career Development Award to promote diversity in clinical trials. I lead the University of Florida Hematologic Radiotherapy Program. In addition, I serve on the Children鈥檚 Oncology Group (COG) Hodgkin Lymphoma Steering Committee, co-leading the Epidemiology and Outcomes working group.